Prevalence, Genotype Diversity, and Distinct Pathogenicity of 205 Gammacoronavirus Infectious Bronchitis Virus Isolates in China during 2019–2023

Ting Xiong,Hangao Xie,Lin Li,Shijin Liang,Meizhen Huang,Chuanzhao Yu,Tingting Zhuang,Xuejing Liang,Dingxiang Liu,Ruiai Chen
DOI: https://doi.org/10.3390/v16060930
2024-06-08
Viruses
Abstract:Gammacoronavirus infectious bronchitis virus (IBV) causes a highly contagious disease in chickens and seriously endangers the poultry industry. The emergence and co-circulation of diverse IBV serotypes and genotypes with distinct pathogenicity worldwide pose a serious challenge to the development of effective intervention measures. In this study, we report the epidemic trends of IBV in China from 2019 to 2023 and a comparative analysis on the antigenic characteristics and pathogenicity of isolates among major prevalent lineages. Phylogenetic and recombination analyses based on the nucleotide sequences of the spike (S) 1 gene clustered a total of 205 isolates into twelve distinct lineages, with GI-19 as a predominant lineage (61.77 ± 4.56%) exhibiting an overall increasing trend over the past five years, and demonstrated that a majority of the variants were derived from gene recombination events. Further characterization of the growth and pathogenic properties of six representative isolates from different lineages classified four out of the six isolates as nephropathogenic types with mortality rates in one-day-old SPF chickens varying from 20–60%, one as a respiratory type with weak virulence, and one as a naturally occurring avirulent strain. Taken together, our findings illuminate the epidemic trends, prevalence, recombination, and pathogenicity of current IBV strains in China, providing key information for further strengthening the surveillance and pathogenicity studies of IBV.
virology
What problem does this paper attempt to address?
The paper primarily explores the epidemic trends, genotype diversity, and pathogenicity of the γ-coronavirus Infectious Bronchitis Virus (IBV) in chickens in China from 2019 to 2023. Specifically, the research team collected 205 IBV isolates from 19 provinces and regions in China and conducted S1 gene sequencing and analysis on these isolates. Through phylogenetic analysis, the researchers classified these isolates into 12 different lineages, with the GI-19 lineage being the most prevalent type, accounting for approximately 61.77% of the total and showing an increasing trend over the past 5 years. Additionally, six other lineages and five variant lineages were detected. Further studies revealed genetic recombination events among these isolates, indicating that genetic recombination might be one of the important mechanisms leading to IBV variation and the emergence of new lineages. The researchers also selected six representative isolates (from the GI-7, GI-13, GI-19, GI-22, GI-28, and GVI-1 lineages) for detailed analysis of their growth characteristics and pathogenicity. The results showed that these isolates exhibited different growth characteristics and pathogenicity. Four of the isolates were classified as nephropathogenic, with mortality rates ranging from 20% to 60%; one isolate exhibited a weaker respiratory type; and one was a naturally avirulent strain. In summary, this paper provides a comprehensive analysis of the monitoring data of IBV in China over the past 5 years, revealing the epidemic trends, genetic diversity, and pathogenic characteristics of IBV. This information and guidance are crucial for future IBV monitoring and vaccine development.